TEVA-DEFERASIROX (TYPE J)
TEVA-DEFERASIROX (TYPE J)
Approved
DIN Number
02531313
Drug Class
Human
Market Date
N/A
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02531313
AIG Number0151733006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AC03 DEFERASIROX
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification64:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DEFERASIROXActive
Strength: 360 MG
Monograph: DEFERASIROX